Dealytics Weekly M&A Review
Weekly review of M&A deals, announcements, news, and insights.

Dealytics Weekly M&A Review

Welcome to the Dealytics weekly review where we list a summary of the top M&A deals, announcements, insights from the prior week.


Edition 1

  1. Tapestry to acquire Capri Holdings Limited for $8.5 billion (Announced: August 10, 2023)
  2. The Campbell's Company to acquire Sovos Brands from Advent for $2.7 billion (Announced: August 7, 2023)
  3. CD&R to acquire Veritiv for $2.3 billion (Announced: August 7, 2023)
  4. KKR to acquire Simon & Schuster for $1.62 billion from Paramount Global (Announced: August 7, 2023)
  5. STG PARTNERS LLC to acquire Avid Inc for $1.4 billion (Announced: August 10, 2023)
  6. 诺和诺德 to acquire Inversago Pharma for $1.075 billion (Announced: August 10, 2023)

Dealytics has also published its Top M&A Bankers Globally from the First Half of 2023


Deal details below

No alt text provided for this image

(August 10, 2023) Tapestry, the conglomerate behind brands like Coach and Kate Spade has agreed to acquire Capri for $57/share, an approximate 59% premium totaling approximately $8.5 billion.


-----

No alt text provided for this image

(August 7, 2023) Campbell Soup Company has agreed to acquire Sovos Brands Inc. for $23/share from Advent International Corp. for $2.7 billion to bolster Campbell's Meals & Beverages division.


-----

No alt text provided for this image

(August 7, 2023) Private equity company, Clayton, Dubilier & Rice has agreed to acquire Veritiv Corporation, an Atlanta-based packaging company, for $170/share about a 20% premium totaling approximately $2.3 billion.


-----

No alt text provided for this image

(August 7, 2023) Private equity company, KKR, has agreed to acquire book publisher Simon & Schuster for $1.62 billion from Paramount Global in an all cash deal.


-----

No alt text provided for this image

(August 10, 2023) Private equity company, STG Partners have agreed to acquire Avid Technologies, a technology provider for the media and entertainment industry, for $27.05/share, a 32% premium, totaling approximately $1.4 billion.


-----

No alt text provided for this image

(August 10, 2023) Producer of the popular weight loss drugs Ozempic and Wegovy, Novo Nordisk, has agreed to acquire Inversago Pharma, producer of drugs to treat obesity and diabetes through its mechanism of blocking CB1 receptors, for $1.075 billion


要查看或添加评论,请登录

Dealytics的更多文章

社区洞察

其他会员也浏览了